Related Experiment Video
Updated: Feb 23, 2026

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
1Meyer Cancer Center and Department of Pharmacology, Weill Cornell Medicine, 413 East 69(th) Street, New York, NY 10021, USA.
Abstract:
Michael N. Hall is this year's recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell's growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Introduction to Metabolism
Mitogens and the Cell Cycle
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

